2018 Symposium

2017 Symposium

2016 Symposium

2015 Symposium

2015 Agenda and Bios

2015 Symposium Photos

2014 Symposium

2014 Agenda and Bios

2013 Featured Talks

2013 Symposium Photos

Previous Symposia

2018 Featured Talks » Adam Burgoyne



Junior Faculty Presentation
Dual PI3K/BRS4 Inhibition as a Novel Therapeutic Strategy for Hepatocellular Carcinoma


Adam Burgoyne, MD, PhD
UC San Diego Moores Cancer Center






Adam Burgoyne, MD, PhD
Instructor of Medicine
Division of Hematology/Oncology, Department of Medicine
UC San Diego Moores Cancer Center


Dr. Adam Burgoyne is an Instructor of Medicine in the Division of Hematology/Oncology at the UC San Diego Moores Cancer Center. He is a medical oncologist specializing in the treatment of gastrointestinal and hepatobiliary tumors. He received his medical and graduate degrees from Case Western Reserve University School of Medicine and completed his internal medicine residency and hematology/oncology fellowship at UC San Diego Medical Center, where he served as Chief Fellow. He is a physician-scientist with research interests including characterization of the tumor microenvironment of gastrointestinal stromal tumors and rational drug design of targeted therapeutics for personalized therapy of hepatocellular carcinoma.